about
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachTumor-associated macrophages contribute to tumor progression in ovarian cancer.Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched populationPrevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer PatientsAccumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.Targeted cancer therapy--are the days of systemic chemotherapy numbered?Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrenceHigh frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.The duplicitous origin of ovarian cancer.Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potentialDistinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotypeTechniques for following labeled cells in vivo: use of X/Y FISH, techniques to optimize fluorescent detection, and beta-galactosidase detectionNSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.MicroRNA and gynecologic cancers.Biological characteristics of CD133(+) cancer stem cells derived from human laryngeal carcinoma cell line.Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.
P2860
Q26849477-3841C3EF-0E66-48A7-83C8-DE27D4341B0CQ33718878-9583DEDA-FCE9-4FE7-AB1A-0848A76F314EQ33890763-15FF93B2-1244-467D-9D42-D2AD56882989Q34285178-56FB9217-E5F4-4881-8A7E-0D938D3572A7Q34372200-69E9A419-4E2C-4F93-A6E8-CA19FB144CE2Q35195618-4005A36B-CE3F-4BFF-8A92-4AD390FF7FCEQ35837949-13302EE6-F734-4619-B7EE-BE9BF165374FQ35844366-86046F0D-2724-4684-B76B-F63D87C8D31CQ36140826-EF07A612-D9C6-43DD-AC1F-5231D85CAC6BQ36174805-EB984261-8541-46A7-B87B-FD820D5F9697Q36563742-BDB9C00C-74F2-462B-8BCE-CA5425C3B721Q36654413-2F6B4555-6089-4721-8C90-36110C8B91CDQ36791997-10265B35-40C9-434D-A003-08AF0C24E7C7Q36919484-F8C96253-0EE3-4342-9583-26E1F4C61B60Q36989636-D9EE9197-A913-4D4A-8A4A-67B4A8999E1EQ36999077-1B306FAB-F342-4585-AB71-8703DDEF39E9Q37272169-78C3AF3F-EF57-4287-B71A-095D0266E2B8Q37687793-4844F994-B9B2-4565-AF39-62CF65CB24D2Q38813155-B6B2B9F5-B733-4BE4-B6EE-851B63600322Q38943910-D4082892-DFDE-4730-BF90-5DC6A8F00288Q45612220-17537F24-AF13-4FC2-8F1D-98F377883637Q55084775-96ADE889-B2B0-4FD8-8515-5DE6DE63905EQ55461517-67438E26-D219-409E-84E5-CB56B39C09ED
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ovarian cancer stem cells and inflammation
@ast
Ovarian cancer stem cells and inflammation
@en
type
label
Ovarian cancer stem cells and inflammation
@ast
Ovarian cancer stem cells and inflammation
@en
prefLabel
Ovarian cancer stem cells and inflammation
@ast
Ovarian cancer stem cells and inflammation
@en
P2093
P2860
P356
P1476
Ovarian cancer stem cells and inflammation
@en
P2093
Ayesha Alvero
Ilana Chefetz
P2860
P304
P356
10.4161/CBT.11.8.14967
P577
2011-04-15T00:00:00Z